Granules gets Health Canada nod for arthritis drug Acetaminophen ER tablets

Written by Ruchika Sharma Published On 2021-08-31T12:05:22+05:30 | Updated On 31 Aug 2021 12:05 PM IST

Granules gets Health Canada nod for arthritis drug Acetaminophen ER tablets

Hyderabad: Granules India Limited has recently announced that the company has received marketing approval from Health Canada for Acetaminophen Extended-Release Tablets OTC, 650mg for the treatment of Arthritis Pain.

The product manufactured by Granules is a bioequivalent to the reference listed drug, Tylenol Extended Release 650 Tablets.

Priyanka Chigurupati, Executive Director of Granules USA, Inc. & Granules Pharmaceuticals, Inc. said, "We received the approval within eight months of filing. This is a step towards global expansion of our core molecules. The approval of Acetaminophen Extended-Release Tablets OTC, 650mg, a complex Bi-layer Extended Released based formulations, is a good addition to our portfolio. We will be launching the product in the Canada market soon."

The drug will be manufactured at the Granules manufacturing facility located in Gagillapur, Hyderabad. Granules now have a total of 2 ANDS approvals from Health Canada.

Read also: Granules India arm clears USFDA audit

Granules India is an Indian pharmaceutical manufacturing company that was founded in 1984 named as Triton Laboratories located in Hyderabad, India.

Granules manufactures varieties of drugs including Paracetamol, Ibuprofen, Metformin, and Guaifenesin, on a large scale for customers in the domestic as well as international markets.

Read also: Granules India gets 2 USFDA observations for Chantilly facility

granules indiagranules newsacetaminophen extended release tabletstylenol extended release 650 tabletsarthritis pain

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751